Table 4.
Overview of FGFR-altered cell lines included in the 134 cancer cell line panel.
| Cell line | Disease | FGFR alteration |
|---|---|---|
| AN3-CA | Endometrial adenocarcinoma | FGFR2 p.N549K |
| KATO III | Gastric signet ring cell adenocarcinoma | FGFR2 amplification |
| KG-1 | Acute myelogenous leukemia | FGFR1OP2-FGFR1 |
| KMS-11 | Multiple myeloma | FGFR3 p.Y373C |
| NCI-H716 | Colorectal adenocarcinoma | FGFR2-COL14A1 |
| RT-4 | Bladder transitional cell carcinoma | FGFR3-TACC3 |
| SNU-16 | Gastric adenocarcinoma | FGFR2 amplification |
| SW780 | Bladder transitional cell carcinoma | FGFR3-BAIAP2L1 |